Parallax Volatility Advisers, L.P. Immuno Gen, Inc. Put Options Transaction History

Parallax Volatility Advisers, L.P.

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	BUY	$12.46 - $29.95 $660,380 - $1.59 Million	53,000 Added 2944.44%	54,800 $1.62 Million
Q3 2023 Nov 14, 2023	SELL	$14.09 - $19.87 $2.58 Million - $3.64 Million	-183,400 Reduced 99.03%	1,800 $28,000
Q2 2023 Aug 14, 2023	BUY	$3.75 - $20.05 $694,500 - $3.71 Million	185,200 New	185,200 $3.49 Million
Q1 2022 May 16, 2022	BUY	$4.26 - $7.48 $1,704 - $2,992	400 New	400 $2,000
Q2 2019 Aug 14, 2019	SELL	$1.8 - $3.3 $360,000 - $660,000	-200,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$2.41 - $5.91 $482,000 - $1.18 Million	200,000 New	200,000 $542,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.